Benzinga Becton, Dickinson Wins FDA Clearance For Next-Gen Breast Biopsy Device, Launch Set For 2026
The FDA clears Becton Dickinson's EnCor EnCompass breast biopsy system, with a U.S. launch planned for early 2026. read more
The FDA clears Becton Dickinson's EnCor EnCompass breast biopsy system, with a U.S. launch planned for early 2026. read more